1. IL‐7 downregulates IL‐7Rα expression in human CD8 T cells by two independent mechanisms. Issue 2 (4th December 2012) Authors: Ghazawi, Feras M; Faller, Elliott M; Sugden, Scott M; Kakal, Juzer A; MacPherson, Paul A Journal: Immunology and cell biology Issue: Volume 91:Issue 2(2013) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IL‐7 induces clathrin‐mediated endocytosis of CD127 and subsequent degradation by the proteasome in primary human CD8 T cells. Issue 2 (29th September 2015) Authors: Faller, Elliott M; Ghazawi, Feras M; Cavar, Marko; MacPherson, Paul A Journal: Immunology and cell biology Issue: Volume 94:Issue 2(2016) Page Start: 196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Infection with antiretroviral-susceptible HIV in an individual adherent to pre-exposure prophylaxis: strategies for treatment initiation. (May 2021) Authors: Hughes, Jessica M; Tan, Darrell HS; Anderson, Peter; Bodhinayake, Janani; MacPherson, Paul A Journal: International journal of STD & AIDS Issue: Volume 32:Number 6(2021) Page Start: 578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Jak/STAT and PI3K signaling pathways have both common and distinct roles in IL-7-mediated activities in human CD8+ T cells. Issue 1 (26th September 2013) Authors: Crawley, Angela M; Vranjkovic, Agatha; Faller, Elliott; McGuinty, Michaeline; Busca, Aurelia; Burke, Stephanie C; Cousineau, Sophie; Kumar, Ashok; MacPherson, Paul A; Angel, Jonathan B Journal: Journal of leukocyte biology Issue: Volume 95:Issue 1(2014) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Routinized Syphilis Screening Among Men Living With Human Immunodeficiency Virus: A Stepped Wedge Cluster Randomized Controlled Trial. (27th June 2021) Authors: Burchell, Ann N; Tan, Darrell H S; Grewal, Ramandip; MacPherson, Paul A; Walmsley, Sharon; Rachlis, Anita; Andany, Nisha; Mishra, Sharmistha; Gardner, Sandra L; Raboud, Janet; Fisman, David; Cooper, Curtis; Gough, Kevin; Maxwell, John; Rourke, Sean B; Rousseau, Rodney; Mazzulli, Tony; Salit, Irvi... Journal: Clinical infectious diseases Issue: Volume 74:Number 5(2022) Page Start: 846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity. Issue 10 (8th October 2020) Authors: McGuinty, Michaeline; Angel, Jonathan B; Cooper, Curtis L; Cowan, Juthaporn; MacPherson, Paul A; Kumar, Ashok; Murthy, Sanjay; Sy, Richmond; Dennehy, Michelle; Tremblay, Nancy; Byrareddy, Siddappa N; Cameron, D William Journal: BMJ open Issue: Volume 10:Issue 10(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity. Issue 10 (8th October 2020) Authors: McGuinty, Michaeline; Angel, Jonathan B; Cooper, Curtis L; Cowan, Juthaporn; MacPherson, Paul A; Kumar, Ashok; Murthy, Sanjay; Sy, Richmond; Dennehy, Michelle; Tremblay, Nancy; Byrareddy, Siddappa N; Cameron, D William Journal: BMJ open Issue: Volume 10:Issue 10(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity. Issue 10 (8th October 2020) Authors: McGuinty, Michaeline; Angel, Jonathan B; Cooper, Curtis L; Cowan, Juthaporn; MacPherson, Paul A; Kumar, Ashok; Murthy, Sanjay; Sy, Richmond; Dennehy, Michelle; Tremblay, Nancy; Byrareddy, Siddappa N; Cameron, D William Journal: BMJ open Issue: Volume 10:Issue 10(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity. Issue 10 (8th October 2020) Authors: McGuinty, Michaeline; Angel, Jonathan B; Cooper, Curtis L; Cowan, Juthaporn; MacPherson, Paul A; Kumar, Ashok; Murthy, Sanjay; Sy, Richmond; Dennehy, Michelle; Tremblay, Nancy; Byrareddy, Siddappa N; Cameron, D William Journal: BMJ open Issue: Volume 10:Issue 10(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity. Issue 10 (8th October 2020) Authors: McGuinty, Michaeline; Angel, Jonathan B; Cooper, Curtis L; Cowan, Juthaporn; MacPherson, Paul A; Kumar, Ashok; Murthy, Sanjay; Sy, Richmond; Dennehy, Michelle; Tremblay, Nancy; Byrareddy, Siddappa N; Cameron, D William Journal: BMJ open Issue: Volume 10:Issue 10(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗